Editorial | Uncertain Backing for the FDA's Biologics Evaluation
FDA Rejection of Replimune's RP1: The FDA rejected Replimune's RP1 immunotherapy for metastatic melanoma due to insufficient evidence of effectiveness, despite the Public Health Service Act not requiring such evidence for approval.
Understanding Potency vs. Effectiveness: The term "potency" refers to the amount of a product needed to achieve a certain effect in laboratory settings, which is distinct from "effectiveness" in clinical applications.
Historical Context of the Biologics Act: The original Biologics Act of 1902 included a requirement for "efficaciousness," but this was removed by the Senate during the consolidation into the Public Health Service Act in 1944.
Implications of Legislative Changes: The removal of the efficacy requirement has implications for how biologics are evaluated and approved, potentially affecting patient access to effective treatments.
Trade with 70% Backtested Accuracy
Analyst Views on CVX
About CVX
About the author

- Oil Price Recovery: As of February 2026, West Texas Intermediate (WTI) prices have rebounded to $57 per barrel, down $15 from early 2025, indicating renewed investor interest in energy stocks amidst a backdrop of previously declining oil prices.
- Energy Sector Leadership: The State Street Energy Select Sector SPDR ETF has surged 23% year-to-date, significantly outperforming the S&P 500's 2% increase, reflecting a resurgence of investor confidence in the energy sector and suggesting potential future investment opportunities.
- Impact of U.S. Foreign Policy: U.S. military actions in Venezuela have sparked optimistic expectations for major oil companies like Chevron and ExxonMobil, which may gain access to the world's largest oil reserves, further driving their stock prices higher.
- Shift in Investor Sentiment: As interest in AI-related stocks wanes, investors are turning to energy stocks as a reliable long-term investment choice, although the market must remain cautious of potential geopolitical risks.
- Energy Stock Surge: As of February 11, 2026, the State Street Energy Select Sector SPDR ETF has risen 23% year-to-date, significantly outperforming the S&P 500's less than 2% increase, indicating strong investor confidence in the energy sector.
- Impact of U.S. Policy: Following the U.S. military's detention of Venezuelan President Maduro on January 3, investors believe that major oil companies like Chevron and ExxonMobil may gain special access to Venezuela's 19.4 billion barrels of oil reserves, potentially driving oil prices higher and enhancing their market positions.
- Escalating Geopolitical Risks: With rising tensions between the U.S. and Iran, particularly the deployment of a carrier group in the region, the market anticipates that any conflict could lead to a temporary spike in global oil prices, further stimulating energy stock performance.
- Shift to Energy Investments: Amidst fatigue in AI-related stocks, some investors are reallocating funds to energy stocks, viewing them as a more reliable long-term investment, although experts caution that restoring Venezuela's oil sector will require years and substantial capital.
- Acquisition Plan: Valero Energy (VLO) is poised to purchase up to 6.5 million barrels of Venezuelan crude in March, potentially becoming the largest foreign refiner of Venezuelan oil since the U.S. captured President Maduro, significantly enhancing its market position.
- Production Increase: If Valero secures 10 or more cargoes, it could achieve a refining capacity of approximately 210,000 barrels per day, potentially surpassing Chevron (CVX) as the top U.S. refiner of Venezuelan crude, further solidifying its industry leadership.
- Chevron's Supply: Chevron is expected to increase its Venezuelan crude exports from 220,000 barrels per day in January to 300,000 barrels per day in March, with Valero set to receive most of this supply, ensuring sustained growth in its refining capacity.
- Refining Capacity Expansion: Following an expansion at its Port Arthur refinery, Valero's total refining capacity for Venezuelan crude has reached approximately 240,000 barrels per day, positioning the company to enhance its competitiveness in the heavy oil market.
- Financial Strain on Universities: Universities are facing increased financial pressure due to rising costs.
- Impact of Federal Funding Cuts: President Donald Trump's initiatives to reduce federal funding are affecting many educational institutions.

Valero's Acquisition: Valero is set to purchase a significant amount of Venezuelan crude oil cargoes from Chevron, according to sources.
Market Impact: This move indicates a potential shift in the oil market dynamics, particularly concerning Venezuelan oil exports.
- New License Issued: The U.S. Treasury has issued a general license allowing international oil companies, including Chevron, to negotiate and sign contracts for oil and gas extraction in Venezuela, paving the way for global oil firms to re-enter the country.
- Tax Requirements: Under the new license, participating companies must pay oil and gas royalties or taxes to Venezuela or its state-run energy company, with these funds deposited into a U.S. Treasury account for foreign governments, ensuring transparency in fund allocation.
- Legal Adjustment Context: The license announcement aligns with adjustments made by Venezuela's interim government to its hydrocarbon law aimed at easing state control over the oil industry, although major U.S. firms remain cautious about investing.
- Market Reaction: Following this news, stocks of major oil companies like Chevron, BP, and Shell rose between 0.5% and 1.7%, indicating a positive market response to the new investment opportunities.









